Key result
Cutaneous manifestations were independent predictors of transient ischaemic attack (OR 2.850; 95% CI 1.562-5.202) and stroke (OR 1.832; 95% CI 1.024-3.277) in patients with primary APS.
Why the study?
Are cutaneous manifestations associated with an increased risk of cerebrovascular events in patients with antiphospholipid syndrome?
Cross-Sectional (n=508)
Are cutaneous manifestations associated with an increased risk of cerebrovascular events in patients with antiphospholipid syndrome?
Odds Ratio: 2.85 (95% CI 1.562–5.202)
p-value: p=0.001
Cutaneous manifestations in patients with antiphospholipid syndrome are strongly associated with cerebrovascular events, highlighting the need for careful neurological monitoring in this subgroup.
Cutaneous manifestations may flag higher cerebrovascular risk in PAPS; leaves open whether intensified monitoring is warranted pending prospective validation.
Objectives To investigate a possible relationship between cerebrovascular, such as stroke and transient ischaemic attack, and various cutaneous manifestations (livedo reticularis, skin ulcerations, pseudovasculitis lesions, superficial cutaneous necrosis and digital gangrene) in antiphospholipid syndrome (APS). This report is based on a Serbian cohort of APS patients. Methods A total of 508 antiphospholipid syndrome APS patients were assessed: 360 with primary (PAPS) and 148 with APS associated with SLE (SAPS). Antiphospholipid antibodies analysis included detection of anti-cardiolipin (IgG/IgM), anti-ß 2 glycoprotein I (IgG/IgM) and positive lupus anticoagulant test. Results The prevalence of cutaneous manifestations in our cohort was significantly higher in the SAPS group (76.4% vs. 27.2%, p = 0.0001). In both groups, the most common manifestation was livedo reticularis. The majority of cutaneous manifestations were significantly associated with cerebrovascular events in SAPS and PAPS. Cutaneous manifestations were independent predictors of transient ischaemic attack and stroke in PAPS patients (odds ratio 2.850, 95% confidence interval 1.562–5.202, p = 0.001, odds ratio 1.832, 95% confidence interval 1.024–3.277, p = 0.041, respectively). Conclusion In this cross-section analysis of a large cohort of Serbian APS patients, there was a strong relationship between cutaneous and cerebrovascular manifestations, suggesting a more cautious approach regarding neurological symptoms, especially in PAPS patients with cutaneous manifestations present.
No takes yet. Share an insight, caveat, or question.
Stojanovich et al. (2018) conducted a cross-sectional in Antiphospholipid syndrome (APS) (n=508). Cutaneous manifestations vs. No cutaneous manifestations was evaluated on Transient ischaemic attack (OR 2.850, 95% CI 1.562-5.202, p=0.001). Cutaneous manifestations were independent predictors of transient ischaemic attack (OR 2.850; 95% CI 1.562-5.202) and stroke (OR 1.832; 95% CI 1.024-3.277) in patients with primary APS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: